HNRNPC and adrenal cortex carcinoma: The DFS study revealed a connection between high HNRNPC expression and a poor prognosis for LUAD (P = 0.037), ACC (P = 3.6e−05), and BLCA (P = 0.037) patients from the TCGA (Figure 3B).